Real-time enrollment status for this endometrial cancer clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 11:13 AM UTC
| NCT Number | NCT05640999 |
| Recruiting Status | Recruiting |
| Condition | Endometrial Cancer |
| Phase | PHASE2 |
| Target Enrollment | 393 participants |
| Active Locations | 72 sites in the US |
| Sponsor | Canadian Cancer Trials Group |
| Last Updated on CT.gov | July 14, 2026 (3 days ago) |
As of July 17, 2026: Clinical trial NCT05640999 is currently recruiting participants. This phase2 study for endometrial cancer is actively seeking new participants at 72 locations across the United States. The study is sponsored by Canadian Cancer Trials Group. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05640999 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 72 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05640999 was last updated 3 days ago (July 14, 2026). HelloStudys verifies this status automatically.